Cardiovascular outcomes (TRIUMPH-Outcomes results expected 20282029) Cancer risk (very long-term monitoring needed) Effects in special populations (elderly, multiple comorbidities) Reassurance: Phase 2 participants stopping medication in extension showed reversibility of side effects, including dysesthesia
Ozempic is approved to help manage type 2 diabetes and reduce cardiovascular risk, while Wegovy is approved to assist with weight loss and for chronic weight management (in conjunction with a reduced-calorie diet and increased physical activity) in people with obesity or who are overweight with at least one weight-related condition
Hyaluronic Acid Acting as an oral moisturizer, it hydrates the skin, supports collagen production, reduces wrinkles, and smoothens texturekeeping skin flexible and radiant
Furthermore, decreases in body weight associated with GLP-1RAs differed between the CV outcomes trials, with mean body weight decreases from baseline of 2.3 kg at 36 months in the LEADER trial (median dose of liraglutide: 1.78 mg once-daily) and 3.6 and 4.9 kg at 104 weeks in the SUSTAIN-6 trial (for 0.5 and 1.0 mg once-weekly, respectively)
See what you think, I think this time I even got the last word